Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie has recently completed a Phase 3b clinical ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

Sales of rhCollagen and bioinks primed for augmentation following new U.S.-based commercial executive hire -- Raised $3.6 million in registered direct offering in second quarter - REHOVOT ...

ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1570 in its research report dated August 19, 2025.

AbbVie announced an update on their ongoing clinical study. The pharmaceutical giant is conducting a Phase 1b clinical study ...